Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

The S&P 500 fell 0.8% on Monday, Feb. 3, as investors reacted to tariffs on major U.S. trading partners while awaiting key ...

Goldman has recently reduced Moderna Inc (MRNA) stock to Neutral rating, as announced on January 29, 2025, according to Finviz. Earlier, on December 18, 2024, Argus had reduced the stock from a Buy to ...

The S&P 500 Index ( $SPX) ( SPY) today is down -0.95%, the Dow Jones Industrials Index ( $DOWI ) ( DIA) is down -0.51%, and the Nasdaq 100 Index ( $IUXX) ( QQQ) is down -1.12%. March E-mini S&P ...

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among ...

NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with a market capitalization of $150 billion and annual revenue exceeding $59 billion, announced today that its Phase 3 BREAKWATER study ...

A US-based pharmaceutical company known for its revolutionary mRNA technology, has completed construction of its Moderna Innovation and Technology Centre (MITC) at Harwell in Oxfordshire.